MiR-409-3p Regulates Angiogensis, Brown Fat Adiposity and Insulin Resistance
MiR-409-3p 调节血管生成、棕色脂肪肥胖和胰岛素抵抗
基本信息
- 批准号:10615029
- 负责人:
- 金额:$ 61.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:3&apos Untranslated Regions3T3-L1 CellsAblationAccelerationAdipocytesAdipose tissueAgeAngiogenesis InhibitionAngiogenesis InhibitorsAnimal ModelBindingBiological AssayBrown FatCell ProliferationCoculture TechniquesCodeDevelopmentDietEndothelial CellsEnergy MetabolismExcisionFatty acid glycerol estersFunctional disorderGene ExpressionGenesGrowthGrowth FactorHarvestHigh Fat DietHomeoboxHormonesHumanImmunohistochemistryImpairmentInsulin ResistanceIntravenousLengthMAP3K1 geneMeasuresMetabolicMetabolic DiseasesMetabolic dysfunctionMetabolismMicroRNAsMolecularMusNon-Insulin-Dependent Diabetes MellitusNucleotidesNutrientObese MiceObesityOrganOrganoidsPECAM1 genePatientsPhenocopyPhosphotransferasesPlasmaPlayProteinsRegulationRoleSamplingSignal PathwaySignal TransductionSkinSmall Interfering RNAStainsStimulusTestingTherapeutic InterventionThermogenesisTissuesTranscriptUntranslated RNAVascular Endothelial Growth FactorsVascularizationWaste ProductsWestern BlottingZinc FingersZinc deficiencyangiogenesiscell growthcell motilitydiabeticdiet-induced obesitydisorder riskendothelial dysfunctionglucose toleranceimprovedin vivoinhibitorinsightinsulin sensitivityinsulin toleranceknock-downlocked nucleic acidmiRNA expression profilingnon-diabeticobesity developmentoverexpressionprogramsresponsesubcutaneoustranscriptome sequencing
项目摘要
PROJECT SUMMARY/ABSTRACT
White and brown adipose tissues are highly vascularized organs, capable of plasticity based on
metabolic demands and energy expenditure. However maladaptive regulation of these tissues can lead to
insulin resistance. Critical gaps remain in our understanding of how angiogenesis impacts adipose tissue
dysfunction and overall metabolism. MicroRNAs (miRs) are implicated in the regulation of the angiogenic
response to pathophysiological stimuli. The role of miRs in regulating the angiogenic response in diet-induced
insulin resistance is poorly understood.
Using a miRNA-Seq approach, we identified that miR-409-3p expression was significantly increased in
endothelial cells (ECs) of brown adipose tissue (BAT) of diet-induced obese (DIO) mice and in human diabetic
plasma samples compared to non-diabetic patients. Overexpression of miR-409-3p markedly inhibited EC
growth and migration, whereas miR-409-3p inhibition had the opposite effects. Preliminary studies indicate that
miR-409-3p targets the 3’UTRs of Zinc Finger E-box binding Homeobox 1 (ZEB1) and Mitogen-activated
protein kinase kinase kinase kinase 3 (MAP4K3). Overexpression of miR-409-3p decreased ZEB1 and
MAP4K3 expression in ECs, whereas inhibition had the opposite effect. SiRNA knockdown of ZEB1 or
MAP4K3 expression in ECs phenocopied the effects of miR-409-3p overexpression and significantly
decreased EC proliferation and migration. 3T3-L1 cells or human skin fat organoids co-cultured with
supernatant harvested from ECs overexpressing miR-409-3p had decreased expression of brown adipocyte
markers (UCP1, Cidea) by RT-qPCR and Western blot analyses, whereas supernatant harvested from ECs
deficient in miR-409-3p increased expression of brown adipocyte markers. Systemic intravenous delivery of
LNA-anti-miR-409-3p inhibitor to DIO mice significantly increased angiogenesis by CD31 staining,
accompanied by higher UCP-1 in BAT and sWAT by RT-qPCR, Western blot, and immunohistochemistry
analyses, while improving glucose and insulin tolerance and overall metabolism. Therefore, we hypothesize
that miR-409-3p serves as a critical regulator of EC growth and angiogenesis in adipose tissue and may
improve metabolic dysfunction in DIO. To explore this, we first propose in Aim1 to investigate the molecular
mechanisms by which miR-409-3p regulates EC growth and angiogenesis. In Aim2, we will delineate the
mechanisms by which miR-409-3p in ECs regulates browning in adipose tissues. Finally, in Aim3, we will
explore the effect of miR-409-3p neutralization in the vasculature of adipose tissues and development of DIO
and insulin resistance in mice. Successful completion of these studies will shed insights on the regulatory role
of miR-409-3p between impaired angiogenesis in diet-induced obesity and adipose tissue dysfunction, an
effect that could be exploited for therapeutic intervention in obesity-induced insulin resistance.
项目概要/摘要
白色和棕色脂肪组织是高度血管化的器官,能够基于
然而,这些组织的适应不良调节可能会导致代谢需求和能量消耗。
我们对血管生成如何影响脂肪组织的理解仍存在重大差距。
MicroRNA (miR) 与血管生成的调节有关。
对病理生理刺激的反应 miR 在调节饮食诱导的血管生成反应中的作用。
人们对胰岛素抵抗知之甚少。
使用 miRNA-Seq 方法,我们发现 miR-409-3p 表达在
饮食诱导肥胖 (DIO) 小鼠和人类糖尿病患者棕色脂肪组织 (BAT) 的内皮细胞 (EC)
与非糖尿病患者的血浆样本相比,miR-409-3p 的过度表达显着抑制 EC。
生长和迁移,而 miR-409-3p 抑制则具有相反的作用。
miR-409-3p 靶向锌指 E 盒结合同源盒 1 (ZEB1) 和丝裂原激活的 3’UTR
蛋白激酶激酶激酶激酶 3 (MAP4K3) 的过度表达会降低 ZEB1 和
ECs 中 MAP4K3 的表达,而 ZEB1 或 siRNA 的抑制则产生相反的效果。
EC 中的 MAP4K3 表达反映了 miR-409-3p 过表达的影响,并且显着
共培养的 3T3-L1 细胞或人皮肤脂肪类器官的 EC 增殖和迁移减少。
从过表达 miR-409-3p 的 EC 中收获的上清液降低了棕色脂肪细胞的表达
通过 RT-qPCR 和蛋白质印迹分析标记(UCP1、Cidea),而从 EC 收获上清液
miR-409-3p 缺陷会增加棕色脂肪细胞标志物的表达。
通过 CD31 染色,DIO 小鼠的 LNA-抗 miR-409-3p 抑制剂显着增加血管生成,
RT-qPCR、Western blot 和免疫组织化学显示 BAT 和 swAT 中 UCP-1 较高
分析,同时改善葡萄糖和胰岛素耐受性以及整体代谢。
miR-409-3p 作为脂肪组织中 EC 生长和血管生成的关键调节因子,可能
改善 DIO 的代谢功能障碍 为了探索这一点,我们首先在 Aim1 中提出研究分子机制。
miR-409-3p 调节 EC 生长和血管生成的机制在 Aim2 中,我们将描述
最后,在 Aim3 中,我们将研究 EC 中 miR-409-3p 调节脂肪组织褐变的机制。
探讨 miR-409-3p 中和对脂肪组织脉管系统和 DIO 发育的影响
小鼠胰岛素抵抗的成功完成将有助于揭示其调节作用。
饮食诱导的肥胖中血管生成受损和脂肪组织功能障碍之间的 miR-409-3p 的关系,
可以利用这一效应对肥胖引起的胰岛素抵抗进行治疗干预。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
MicroRNA-409-3p/BTG2 signaling axis improves impaired angiogenesis and wound healing in obese mice.
- DOI:10.1096/fj.202302124rr
- 发表时间:2024-02-08
- 期刊:
- 影响因子:0
- 作者:Furkan Bestepe;George F Ghanem;Colette M Fritsche;James Weston;Sumedha Sahay;Am;a K Mauro;a;Parul S
- 通讯作者:Parul S
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Basak Icli其他文献
Basak Icli的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Basak Icli', 18)}}的其他基金
MiR-409-3p Regulates Angiogensis, Brown Fat Adiposity and Insulin Resistance
MiR-409-3p 调节血管生成、棕色脂肪肥胖和胰岛素抵抗
- 批准号:
10393708 - 财政年份:2021
- 资助金额:
$ 61.09万 - 项目类别:
MiR-409-3p Regulates Angiogensis, Brown Fat Adiposity and Insulin Resistance
MiR-409-3p 调节血管生成、棕色脂肪肥胖和胰岛素抵抗
- 批准号:
10371707 - 财政年份:2021
- 资助金额:
$ 61.09万 - 项目类别:
MiR-409-3p regulates angiogenesis, brown fat adiposity, and insulin resistance
MiR-409-3p 调节血管生成、棕色脂肪肥胖和胰岛素抵抗
- 批准号:
10052898 - 财政年份:2020
- 资助金额:
$ 61.09万 - 项目类别:
相似海外基金
MiR-409-3p Regulates Angiogensis, Brown Fat Adiposity and Insulin Resistance
MiR-409-3p 调节血管生成、棕色脂肪肥胖和胰岛素抵抗
- 批准号:
10393708 - 财政年份:2021
- 资助金额:
$ 61.09万 - 项目类别:
MiR-409-3p Regulates Angiogensis, Brown Fat Adiposity and Insulin Resistance
MiR-409-3p 调节血管生成、棕色脂肪肥胖和胰岛素抵抗
- 批准号:
10371707 - 财政年份:2021
- 资助金额:
$ 61.09万 - 项目类别:
MiR-409-3p regulates angiogenesis, brown fat adiposity, and insulin resistance
MiR-409-3p 调节血管生成、棕色脂肪肥胖和胰岛素抵抗
- 批准号:
10052898 - 财政年份:2020
- 资助金额:
$ 61.09万 - 项目类别:
Genetics of IGF1 and Bone Density: The Role of Nocturnin
IGF1 和骨密度的遗传学:Nocturnin 的作用
- 批准号:
8101832 - 财政年份:1998
- 资助金额:
$ 61.09万 - 项目类别:
Genetics of IGF1 and Bone Density: The Role of Nocturnin
IGF1 和骨密度的遗传学:Nocturnin 的作用
- 批准号:
7885564 - 财政年份:1998
- 资助金额:
$ 61.09万 - 项目类别: